TriangleNCT03051516 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- true
- restrictive Agreement
- false
- limitations And Caveats
- description
- An interim analysis found the intervention to be futile. Therefore, the VIVA trial was ended effective July 31st, 2022, for the University of Washington clinic, and December 31st, 2022, for the University of Alabama Birmingham clinic. Participants were offered the choice of continuing any outstanding visits until the end of the study at the respective sites.
- point Of Contact
- mmadelei@fredhutch.org
- organization
- Fred Hutchinson Cancer Center
- phone
- 206-667-4630
- title
- Margaret M. Madeleine, PhD
Complete source fields
- certain Agreement
- pi Sponsor Employee
- true
- restrictive Agreement
- false
- limitations And Caveats
- description
- An interim analysis found the intervention to be futile. Therefore, the VIVA trial was ended effective July 31st, 2022, for the University of Washington clinic, and December 31st, 2022, for the University of Alabama Birmingham clinic. Participants were offered the choice of continuing any outstanding visits until the end of the study at the respective sites.
- point Of Contact
- mmadelei@fredhutch.org
- organization
- Fred Hutchinson Cancer Center
- phone
- 206-667-4630
- title
- Margaret M. Madeleine, PhD
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice